Anti-PLA2R antibody levels and clinical risk factors for predicting relapse in primary membranous nephropathy
ObjectivesTo explore the predictive value of anti-phospholipase A2 receptor (PLA2R) antibody levels and clinical risk factors for relapse in patients with primary membranous nephropathy (pMN) who achieved remission after immunosuppressive therapy.Metho…